STYLIZED GEOMETRICAL PATTERN & DESIGN

View On IC.GC.CA

APPROVED

on 4 Apr 2025

Last Applicant/ Owned by

Cellusion Inc.

2-5-24, Harumi,Chuo-kuTokyo 104-0053

Serial Number

2230634 filed on 3^rd Aug 2022

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

K1P1J9

STYLIZED GEOMETRICAL PATTERN & DESIGN

Trademark usage description

pharmaceutical preparations, namely, pharmaceutical preparations for use in cell therapy, pharmaceutical preparations for use in natural killer (nk) c Read More

Vienna Information

26 . 1 . 2

EllipsesEllipses

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 4 . 3

Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe

26 . 4 . 6

Quadrilateral figures with one or more convex or concave sides -- Note: Not including elongated surfaces with one or more convex or concave sides (25.3.1).Figures quadrilatérales à un ou plusieurs côtés convexes ou concaves -- Note: Non compris les surfaces allongées avec un ou plusieurs côtés convexes ou concaves (25.3.1).

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 8

Surfaces or backgrounds covered with other repeated geometrical figures or designsSurfaces ou fonds couverts d'autres figures ou motifs géométriques répétés

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 8

BlackNoir

Classification Information

Class [005]
Pharmaceutical preparations, namely, pharmaceutical preparations for use in cell therapy, pharmaceutical preparations for use in natural killer (NK) cell immunotherapy, pharmaceutical preparations for use in T-cell immunotherapy, pharmaceutical preparations for use in gene therapy; diagnostic preparations for medical purposes, namely, diagnostic preparations for clinical laboratory use, diagnostic preparations for in vitro testing for medical use, diagnostic preparations for medical laboratory use, diagnostic preparations for medical purposes for detecting genetic predispositions, diagnostic preparations for medical purposes for detecting mutation in prion genes, in-vitro diagnostic preparations for medical purposes; biological preparations for medical purposes, namely, biological preparations made from human blood cells for cell therapy, biological preparations made from human blood cells for gene therapy, biological preparations made from human blood cells for use in natural killer (NK) cell immunotherapy, biological preparations made from human blood cells for use in T-cell immunotherapy, biological preparations made from living tissues for use in cell therapy, biological preparations made from pluripotent stem cells (iPS cells); stem cells for medical purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; diagnostic media for bacteriological cultures; reagents for medical purposes namely blood grouping reagents for medical purposes, clinical diagnostic reagents, diagnostic biomarker reagents for medical purposes, diagnostic chemical reagents for medical purposes, diagnostic reagents and agents for medical diagnostic use, diagnostic reagents and contrast media for medical purposes, diagnostic reagents for clinical laboratory use, diagnostic reagents for medical diagnostic use, diagnostic reagents for medical laboratory use, diagnostic reagents for medical purposes, veterinary diagnostic reagents; diagnostic biomarker reagents for medical purposes; nucleic acid sequences for medical and veterinary purposes namely for treating bullous keratopathy; reagents for use in medical genetic testing; ophthalmological preparations; reagent paper for medical purposes; solutions for use with contact lenses; medicated preparations namely medicated anti-cavity dental rinses, medicated antibacterial sprays, medicated creams for hydrating the skin, medicated eye-washes, multi-purpose medicated analgesic balms, multi-purpose medicated mentholated salves; collyrium; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for veterinary purposes; eyepatches for medical purposes; dental materials namely, dental materials for stopping the teeth, abrasive fluids for dental purposes, adhesives for dental purposes, amalgam for dental purposes, cements for dental prostheses, composite materials for dental purposes, dental blanks, dental implant materials, dental wax, embedding material for dental purposes, material for dental prostheses, materials for dental fillings; living tissues for transplantation for humans.

Classification kind code

Class [042]
Testing, inspection and research of pharmaceuticals; consulting services in the field of pharmaceutical testing, inspection and research; pharmaceutical research and development; clinical trials; medical research; biological research in the field of regenerative medicine, cell therapy and gene therapy; providing information about medical research in the field of medicine; providing information in the field of testing, inspection and research of using stem cells in the field of regenerative medicine, cell medicine, and gene therapy; providing information in the field of research and development of pharmaceutical preparations; pharmaceutical drug development services; culturing of cells for scientific research purposes in the field of regenerative medicine, cell medicine, and gene therapy; testing, inspection and research of medical treatment methods and techniques in the field of regenerative medicine, cell therapy and gene therapy; testing, inspection and research of cosmetics and foodstuffs; scientific research in the field of genetic engineering; scientific services namely the isolation and cultivation of human tissues and cells in the field of regenerative medicine, cell medicine and gene therapy; analysis of stem cells for scientific research purposes; research and development services in the field of gene expression systems; testing, inspection or research of regenerative medicine services; testing, inspection and scientific research and medical research in the field of regenerative medicine, cell medicine and gene therapy; testing and research services relating to medical apparatus and medical instruments in the field of regenerative medicine, cell therapy and gene therapy; design and development of computer hardware and software for use in the field of medicine; designing of medical apparatus and instruments; computer software design, computer programming, or maintenance of computer software; providing computer programs for data processing in the field of regenerative medicine, cell therapy and gene therapy on data networks; rental of laboratory equipment and instruments; culturing of cells for others for scientific research purposes in the field of regenerative medicine, cell medicine and gene therapy; genetic testing of cells for scientific research purposes in the field of regenerative medicine, cell medicine and gene therapy; culturing of cells collected from patients for scientific research purposes, namely, for transplantation in the field of regenerative medicine, cell medicine, and gene therapy; providing quality assurance services in the field of therapeutic compositions, namely, compositions containing cells for regenerative medicine services, gene therapy, and viruses; quality assurance consultancy services in the field of therapeutic compositions, namely, compositions containing cells for regenerative medicine services, gene therapy, and viruses; providing quality control for the pharmaceutical industry, providing quality control in the field of therapeutic compositions, namely, compositions containing cells for regenerative medicine services, gene therapy, and viruses; consultancy services in the field of quality control for the pharmaceutical industry, consultancy services in the field of quality control in the field of therapeutic compositions, namely, compositions containing cells for regenerative medicine services, gene therapy, and viruses.

Classification kind code

Class [044]
Providing medical information in the field of regenerative medicine, cell therapy, and gene therapy; medical and veterinary information services provided via the Internet; providing information to patients in the field of administering medication; medical care and analysis services relating to patient treatment; health clinic services namely dental clinics, emergency medicine clinics, medical clinic services, medical clinics, medical treatment services provided by clinics and hospitals, mobile medical clinic services, operation and management of medical clinics, veterinary clinics, health clinic services in the field of regenerative medicine services; collection, analysis, and provision of information in the field of medical care; treatment or diagnosis using regenerative medicine services; treatment or diagnosis in the field of stem cell medicine; dietary and nutritional guidance; animal husbandry; veterinary services; medical equipment rental; providing medical and pharmaceutical consultancy and information services relating to biopharmaceutical products; cultured cell bank services for medical transplantation in the field of regenerative medicine, cell medicine, and gene therapy; medical treatment using cultured cells in the field of regenerative medicine, cell medicine, and gene therapy; stem cell bank services in the field of regenerative medicine, cell medicine, and gene therapy; stem cell therapy services in the field of regenerative medicine, cell medicine, and gene therapy; providing medical information in the field of collection and preservation of cells in the field of regenerative medicine, cell medicine, and gene therapy; providing medical information in the field of analysis and processing cells in the field of regenerative medicine, cell medicine, and gene therapy; providing medical information in the field of regenerative medicine services; collection and preservation of biological tissues, blood and cells in the field of regenerative medicine, cell medicine, and gene therapy; medical testing services relating to the diagnosis and treatment of disease performed by culturing medical and clinical cells in the field of regenerative medicine, cell medicine, and gene therapy; medical services namely analysis and processing of blood plasma and stem cells being medical services, medical services relating to the removal, treatment and processing of stem cells, conducting of medical examinations, cultured cell bank services for medical transplantation, genetic testing for medical purposes, information, advisory and consultancy services in the field of medical care and analysis services, information, advisory and consultancy services in the field of medical testing services; providing information and medical data for diagnosis and medical treatment in the field of regenerative medicine, cell therapy, and gene therapy; medical treatment services with cell preparations in the field of regenerative medicine, cell medicine, and gene therapy; medical professional consulting services in the field of regenerative medicine, cell medicine, and gene therapy; preservation of human blood for use as a source of stem cells in the field of regenerative medicine, cell medicine, and gene therapy; genetic testing for medical purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories.

Classification kind code

Mark Details

Serial Number

2230634

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 135 on 7^th Mar 2024	Amendment to Application
Submitted for opposition 257 on 30^th Nov 2023	Designation Notification - Madrid Protocol
Submitted for opposition 210 on 30^th Nov 2023	IR Correction
Submitted for opposition 256 on 30^th Oct 2023	Notification of Possible Opposition Sent
Submitted for opposition 135 on 9^th Mar 2023	Amendment to Application
Submitted for opposition 257 on 29^th Dec 2022	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 28^th Dec 2022	Formalized
Submitted for opposition 1 on 28^th Dec 2022	Created
Submitted for opposition 30 on 3^rd Aug 2022	Filed
Submitted for opposition 228 on 3^rd Aug 2022	International Registration